{"altmetric_id":2170963,"counts":{"readers":{"mendeley":4,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["toxicovigilance"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa60c3cf058f610006afc","authors":["H. Bruce Ostler"],"doi":"10.1001\/archopht.1975.01010020446011","first_seen_on":"2014-03-08T11:06:48+00:00","issns":["0003-9950"],"journal":"Archives of Ophthalmology","last_mentioned_on":1394276800,"links":["http:\/\/archopht.jamanetwork.com\/article.aspx?articleid=631560"],"pdf_url":"http:\/\/archopht.jamanetwork.com\/data\/Journals\/OPHTH\/17841\/archopht_93_6_011.pdf","pubdate":"1975-01-01T00:00:00+00:00","publisher":"American Medical Association","publisher_subjects":[{"name":"Ophthalmology And Optometry","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["ophthalmology"],"title":"Cycloplegics and Mydriatics: Tolerance, Habituation, and Addiction to Topical Administration","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/cycloplegics-mydriatics-tolerance-habituation-addiction-topical-administration"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4505692,"mean":5.1008244577038,"rank":3123944,"this_scored_higher_than_pct":22,"this_scored_higher_than":1019052,"rank_type":"exact","sample_size":4505692,"percentile":22},"similar_age_3m":{"total_number_of_other_articles":107601,"mean":8.2799128624536,"rank":75974,"this_scored_higher_than_pct":22,"this_scored_higher_than":24024,"rank_type":"exact","sample_size":107601,"percentile":22},"this_journal":{"total_number_of_other_articles":736,"mean":3.0151238095238,"rank":522,"this_scored_higher_than_pct":21,"this_scored_higher_than":155,"rank_type":"exact","sample_size":736,"percentile":21},"similar_age_this_journal_3m":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Student  > Ph. D. Student":1,"Student  > Master":1,"Other":1},"by_discipline":{"Medicine and Dentistry":3}}},"geo":{"twitter":{"PT":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/toxicovigilance\/status\/442255072278626304","license":"public","citation_ids":[2170963],"posted_on":"2014-03-08T11:06:40+00:00","author":{"name":"Toxicovigilance","url":"http:\/\/www.emcdda.europa.eu\/activities\/action-on-new-drugs","image":"https:\/\/pbs.twimg.com\/profile_images\/689911914940518401\/rMWshq1J_normal.jpg","description":"@EMCDDA toxicovigilance feed on new psychoactive substances. SAE: serious adverse event; AC: analytically confirmed; RFI: request for information","id_on_source":"toxicovigilance","tweeter_id":"2291691778","geo":{"lt":38.71667,"ln":-9.13333,"country":"PT"},"followers":786},"tweet_id":"442255072278626304"}]}}